MedPath

Nanjing Medical University First Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation

Not Applicable
Recruiting
Conditions
Aortic Valve Disease
Interventions
Drug: Medical therapy
Device: Transcatheter Aortic Valve Implantation
First Posted Date
2021-04-28
Last Posted Date
2024-03-21
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
210
Registration Number
NCT04864145
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus

Not Applicable
Completed
Conditions
Type 2 Diabetes
Interventions
Device: Personal flash glucose mornitoring
Device: Professional flash glucose mornitoring
First Posted Date
2021-04-19
Last Posted Date
2021-09-27
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
239
Registration Number
NCT04847219
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

Sacral Nerve Stimulation for Mild-to-Moderate or Refractory Rheumatoid Arthritis

Not Applicable
Conditions
Rheumatoid Arthritis
Interventions
Device: Sham stimulation
Device: Sacral nerve stimulation
First Posted Date
2021-03-29
Last Posted Date
2022-03-04
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
60
Registration Number
NCT04821050
Locations
🇨🇳

Dinglei Su, Nanjing, Jiangsu, China

Intensive Control of Blood Pressure in Acute Ischemic Stroke After Endovascular Therapy on Clinical Outcome (CRISIS I)

Not Applicable
Terminated
Conditions
Acute Ischemic Stroke
Interventions
Other: Intensive BP lowering
First Posted Date
2021-03-01
Last Posted Date
2023-07-24
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
205
Registration Number
NCT04775147
Locations
🇨🇳

Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

Drug-coating Balloon Treatment in Coronary Artery Disease

Recruiting
Conditions
Coronary Artery Disease
Interventions
Device: DCB treatment
First Posted Date
2020-02-05
Last Posted Date
2024-11-15
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
3000
Registration Number
NCT04255563
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon

Not Applicable
Completed
Conditions
Coronary Artery Disease
Interventions
Device: IVUS guidance
Device: Angiography guidance
First Posted Date
2020-02-05
Last Posted Date
2024-11-15
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
260
Registration Number
NCT04255043
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions

Not Applicable
Active, not recruiting
Conditions
Coronary Artery Disease
Interventions
Device: Drug-coating balloon
First Posted Date
2020-01-27
Last Posted Date
2024-07-03
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
784
Registration Number
NCT04242134
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

Circulating Non-coding RNA in Acute Ischemic Stroke with Endovascular Treatment (EVTRNA)

Recruiting
Conditions
Stroke, Ischemic
Endovascular Treatment
Stroke, Acute
Interventions
Genetic: Sequencing of circRNA/lncRNA/miRNA
First Posted Date
2020-01-18
Last Posted Date
2024-11-22
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
300
Registration Number
NCT04230785
Locations
🇨🇳

Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

Conservative Versus Surgical Treatment of Impacted Femoral Neck Fracture in Patient 75 Years Old and Older

Not Applicable
Completed
Conditions
Femoral Neck Fractures
Interventions
Procedure: Surgical Treatment for Impacted Femoral Neck Fracture
First Posted Date
2020-01-07
Last Posted Date
2020-01-07
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
154
Registration Number
NCT04219943

177Lu-PSMA-I&T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer

Phase 2
Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
First Posted Date
2019-12-06
Last Posted Date
2019-12-06
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
30
Registration Number
NCT04188587
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath